β-Carbonylsilanes with a silacyclohexane skeleton and additional C-functionalized organyl groups at the silicon atom: synthesis, reactivity, and NMR-spectroscopic characterization
摘要:
A series of novel beta-carbonylsilanes, with a silacyclohexane skeleton and additional C-functionalized organyl groups at the silicon atom, were synthesized, their reactivity was explored, and they were structurally characterized by multinuclear NMR spectroscopy. The aim of these investigations was to provide the basis for the development of novel silicon-based drugs containing a silacyclohexane skeleton, with a CH2C(O)R substituent and an additional C-functionalized organyl group at the silicon atom. (C) 2004 Elsevier B.V. All rights reserved.
β-Carbonylsilanes with a silacyclohexane skeleton and additional C-functionalized organyl groups at the silicon atom: synthesis, reactivity, and NMR-spectroscopic characterization
摘要:
A series of novel beta-carbonylsilanes, with a silacyclohexane skeleton and additional C-functionalized organyl groups at the silicon atom, were synthesized, their reactivity was explored, and they were structurally characterized by multinuclear NMR spectroscopy. The aim of these investigations was to provide the basis for the development of novel silicon-based drugs containing a silacyclohexane skeleton, with a CH2C(O)R substituent and an additional C-functionalized organyl group at the silicon atom. (C) 2004 Elsevier B.V. All rights reserved.
β-Carbonylsilanes with a silacyclohexane skeleton and additional C-functionalized organyl groups at the silicon atom: synthesis, reactivity, and NMR-spectroscopic characterization
作者:Jürgen O. Daiß、Christian Burschka、Reinhold Tacke
DOI:10.1016/j.jorganchem.2004.08.048
日期:2005.1
A series of novel beta-carbonylsilanes, with a silacyclohexane skeleton and additional C-functionalized organyl groups at the silicon atom, were synthesized, their reactivity was explored, and they were structurally characterized by multinuclear NMR spectroscopy. The aim of these investigations was to provide the basis for the development of novel silicon-based drugs containing a silacyclohexane skeleton, with a CH2C(O)R substituent and an additional C-functionalized organyl group at the silicon atom. (C) 2004 Elsevier B.V. All rights reserved.